NKTR Short-term downside?: More Patterns for consideration

31 בינו׳ 2019

My chart is getting a bit messy, however, this one does shoe a consistent pattern on both MACD and Stochastic RSI, making this either the BEST time to BUY, or the WORST time to BUY. It may break 50/share by the end of summer, and End of February Earnings could rebound the stock up to $70+ on the Bullish Side over 3-6 months. On the Bearish side, I am still looking at previous numbers $25-37/share before any additional rebound. Again, barring any medical breakthroughs. NOT FINANCIAL ADVICE. Let me know what you think of my ideas, any counter reasoning, or other pertinent/interesting information pertaining to Nektar Therapeutics. Thanks.